Characterizing the Copy Number Variation of Non-Coding RNAs Reveals Potential Therapeutic Targets and Prognostic Markers of LUSC
Lung squamous cell carcinoma (LUSC) has a poor clinical prognosis and a lack of available targeted therapies. Therefore, there is an urgent need to identify novel prognostic markers and therapeutic targets to assist in the diagnosis and treatment of LUSC. With the development of high-throughput sequ...
Guardado en:
Autores principales: | Jinfeng Ning, Fengjiao Wang, Kaibin Zhu, Binxi Li, Qing Shu, Wei Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c1363024477341878f7b39ff89fe1d46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Integrated analyses of copy number variations and gene differential expression in lung squamous-cell carcinoma
por: Yang,Zhao, et al.
Publicado: (2015) -
Association of Serum Amylase Activity and the Copy Number Variation of AMY1/2A/2B with Metabolic Syndrome in Chinese Adults
por: Zhan F, et al.
Publicado: (2021) -
Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence
por: Zhipeng Xu, et al.
Publicado: (2021) -
Research Progress of circRNAs in Glioblastoma
por: Xu Guo, et al.
Publicado: (2021) -
CNV-P: a machine-learning framework for predicting high confident copy number variations
por: Taifu Wang, et al.
Publicado: (2021)